Search

Search Constraints

You searched for: Author/Creator Berger, Eric

Search Results

1. BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. (September 2021)

2. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016)

3. CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy. (6th December 2016)

4. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis. (13th August 2019)

5. Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study. (23rd February 2016)

6. Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis. Issue 5 (8th April 2021)

7. Cytotoxicity assessment, inflammatory properties, and cellular uptake of Neutraplex lipid-based nanoparticles in THP-1 monocyte-derived macrophages. (20th December 2017)

8. Determinants of therapeutic lag in multiple sclerosis. (October 2021)

9. Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort. (24th August 2021)

10. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis. (25th October 2022)